Live Analyst Rating Changes 2642 upgrades, downgrades & price-target moves · freshest Wall Street data, updated daily View live feed →
Analyst Tracker/Marianne Bulot
BofA
Marianne Bulot
Bank of America Securities
Wall Street Analyst
Not yet ranked — too few measurable calls.
100%
Success Rate
+19.7%
Average Return
1 of 1 calls profitable · +8.5% vs benchmark
📈 Across the calls we could measure, roughly 100% of Marianne Bulot's ratings turned a profit when each position was held for 1 year — averaging +19.7% per rating. These figures are computed by 13Foresight from historical prices, not supplied by the analyst.

Rating Distribution

0 Buy 0 Hold 1 Sell
Marianne's Stock Coverage 3 ratings · 2026-06-25
Company Date Position Consensus ⓘ Price Target ⓘ 1-Yr Return
FMS
Fresenius Medical Care
 Oct 15, 2025 SELL Hold
+78.8% avg upside
14 analysts
$22.00
7.71% Downside
 +19.7%
DE:FME
Fresenius Medical Care AG & Co. KGaA
 May 07, 2025 HOLD Hold
+23.1% avg upside
22 analysts
$48.00
13.83% Upside
 ·
CH:YPSN
Ypsomed Holding AG
 Mar 03, 2025 BUY Strong Buy
+43.0% avg upside
2 analysts
$485.00
37.32% Upside
 ·
Marianne Bulot — Frequently Asked Questions
How accurate are Marianne Bulot's stock ratings?
Based on the calls 13Foresight could measure, about 100% of Marianne's ratings were profitable over a one-year hold, with an average return of +19.7% per rating, or +8.5% versus the S&P 500. We score every analyst the same way, from historical prices.
How is Marianne ranked on 13Foresight?
Marianne Bulot is currently ranked unranked . Our rank blends hit rate, average return versus the market, and how many calls we have to judge — so a long, consistent record outweighs a few lucky picks. It is our own calculation, updated daily.
Which stocks does Marianne cover?
Marianne most recently has ratings on FMS, DE:FME, CH:YPSN. See the full coverage table above for positions, price targets and our measured returns.
Where can I see other analyst ratings?
Browse the full analyst leaderboard to compare Wall Street analysts ranked by their measured performance, success rate and average return.

Disclaimer: 13Foresight compiles analyst ratings and price targets from publicly available sources. Performance metrics, rankings and star ratings shown here are calculated independently by 13Foresight from historical market prices and may differ from figures published elsewhere. This information may be incomplete, delayed or inaccurate, is provided for research and informational purposes only, and is not investment advice. The underlying ratings and opinions are those of the respective analysts and their firms; 13Foresight accepts no liability for any decisions made based on this data.